{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:24:14Z","timestamp":1768011854469,"version":"3.49.0"},"reference-count":51,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation (NSF)","doi-asserted-by":"publisher","award":["CHE-1804699"],"award-info":[{"award-number":["CHE-1804699"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation (NSF)","doi-asserted-by":"publisher","award":["MCB-2043248"],"award-info":[{"award-number":["MCB-2043248"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cefotaximase-Munich (CTX-M) extended-spectrum beta-lactamases (ESBLs) are commonly associated with Gram-negative, hospital-acquired infections worldwide. Several beta-lactamase inhibitors, such as clavulanate, are used to inhibit the activity of these enzymes. To understand the mechanism of CTX-M-15 activity, we have determined the crystal structures of CTX-M-15 in complex with two specific classes of beta-lactam compounds, desfuroylceftiofur (DFC) and ampicillin, and an inhibitor, clavulanic acid. The crystal structures revealed that Ser70 and five other residues (Lys73, Tyr105, Glu166, Ser130, and Ser237) participate in catalysis and binding of those compounds. Based on analysis of steady-state kinetics, thermodynamic data, and molecular docking to both wild-type and S70A mutant structures, we determined that CTX-M-15 has a similar affinity for all beta-lactam compounds (ceftiofur, nitrocefin, DFC, and ampicillin), but with lower affinity for clavulanic acid. A catalytic mechanism for tested \u03b2-lactams and two-step inhibition mechanism of clavulanic acid were proposed. CTX-M-15 showed a higher activity toward DFC and nitrocefin, but significantly lower activity toward ampicillin and ceftiofur. The interaction between CTX-M-15 and both ampicillin and ceftiofur displayed a higher entropic but lower enthalpic effect, compared with DFC and nitrocefin. DFC, a metabolite of ceftiofur, displayed lower entropy and higher enthalpy than ceftiofur. This finding suggests that compounds containing amine moiety (e.g., ampicillin) and the furfural moiety (e.g., ceftiofur) could hinder the hydrolytic activity of CTX-M-15.<\/jats:p>","DOI":"10.3390\/ijms23095229","type":"journal-article","created":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T08:04:21Z","timestamp":1651997061000},"page":"5229","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characterization of Interactions between CTX-M-15 and Clavulanic Acid, Desfuroylceftiofur, Ceftiofur, Ampicillin, and Nitrocefin"],"prefix":"10.3390","volume":"23","author":[{"given":"Parvaneh","family":"Ahmadvand","sequence":"first","affiliation":[{"name":"Department of Chemistry, Washington State University, Pullman, WA 99164, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannetsy J.","family":"Avillan","sequence":"additional","affiliation":[{"name":"Paul G Allen School for Global Health, Washington State University, Pullman, WA 99164, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6430-7034","authenticated-orcid":false,"given":"Jacob A.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Washington State University, Pullman, WA 99164, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R.","family":"Call","sequence":"additional","affiliation":[{"name":"Paul G Allen School for Global Health, Washington State University, Pullman, WA 99164, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0693-7860","authenticated-orcid":false,"given":"ChulHee","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Washington State University, Pullman, WA 99164, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"ref_1","unstructured":"CDC (2019). Antibiotic Resistance Threats in the United States."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The New Beta-Lactamases","volume":"352","author":"Jacoby","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijmm.2013.02.008","article-title":"CTX-M-Type Beta-Lactamases: A Successful Story of Antibiotic Resistance","volume":"303","author":"Arena","year":"2013","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.48.4.1204-1214.2004","article-title":"Ambler Class A Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella spp. in Canadian Hospitals","volume":"48","author":"Mulvey","year":"2004","journal-title":"Antimicrobe Agents Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.47.7.2382-2383.2003","article-title":"Discovery of CTX-M-like Extended-Spectrum Beta-Lactamases in Escherichia coli Isolates from Five U.S. States","volume":"47","author":"Moland","year":"2003","journal-title":"Antimicrobe Agents Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/mdr.2008.0827","article-title":"Rapid Emergence of BlaCTX-M among Enterobacteriaceae in U.S. Medical Centers: Molecular Evaluation from the MYSTIC Program (2007)","volume":"14","author":"Castanheira","year":"2008","journal-title":"Microb Drug Resist."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408410490266429","article-title":"Extended-Spectrum Beta-Lactamases (ESbLs): Characterization, Epidemiology and Detection","volume":"30","author":"Shah","year":"2004","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/1040841X.2012.691460","article-title":"Epidemiology and Genetics of CTX-M Extended-Spectrum Beta-Lactamases in Gram-Negative Bacteria","volume":"39","author":"Zhao","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tim.2006.07.008","article-title":"The \u03b2-Lactamase Threat in Enterobacteriaceae, Pseudomonas and Acinetobacter","volume":"14","author":"Livermore","year":"2006","journal-title":"Trends Microbiol."},{"key":"ref_10","first-page":"852","article-title":"ClavulanicAcid: A Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces Clavuligerus","volume":"11","author":"Reading","year":"1977","journal-title":"Am. Soc. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33528","DOI":"10.1074\/jbc.M501251200","article-title":"Clavulanic Acid Inactivation of SHV-1 and the Inhibitor-Resistant S130G SHV-1 b-Lactamase","volume":"280","author":"Sulton","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-biochem-061809-112742","article-title":"Structural Perspective of Peptidoglycan Biosynthesis and Assembly","volume":"81","author":"Lovering","year":"2012","journal-title":"Ann. Rev. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pazos, M., and Peters, K. (2019). Peptidoglycan Bacterial Cell Walls and Membranes, Springer.","DOI":"10.1007\/978-3-030-18768-2_5"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rang, H.P., Dale, M.M., Ritter, J.M., and Flower, R.J. (2006). Drugs Used in the Treatment of Infections and Cancer and Antibacterial Drugs. Textbook of Pharmacology, Church Hill Living Stone. [6th ed.].","DOI":"10.1016\/B978-0-443-06911-6.50050-5"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/cr030102i","article-title":"Bacterial Resistance to Beta-Lactam Antibiotics: Compelling Opportusism, Compelling Opportunity","volume":"105","author":"Fisher","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/medicina47030019","article-title":"Antibiotic Resistance Mechanisms of Clinically Important Bacteria","volume":"47","author":"Giedraitiene","year":"2011","journal-title":"Medicina"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1021\/ja034861u","article-title":"Structural Aspects for Evolution of Beta-Lactamases from Penicillin-Binding Proteins","volume":"125","author":"Meroueh","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC Beta-Lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-Spectrum b-Lactamase-Producing Enterobacteriaceae: An Emerging Public Health Concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-Spectrum Beta-Lactamases: A Clinical Update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.mib.2005.08.014","article-title":"The Threat of Antibiotic Resistance in Gram-Negative Pathogenic Bacteria: \u03b2-Lactams in Peril","volume":"8","author":"Thomson","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1574-6976.2011.00290.x","article-title":"Broad-Specificityeffluxpumpsand Their Role in Multidrug Resistance of Gram-Negative Bacteria","volume":"36","author":"Nikaido","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/protein\/4.7.805","article-title":"Site-Directed Mutagenesis on TEM-1 \u03b2-Lactamase: Role of Glu166 in Catalysis and Substrate Binding","volume":"4","author":"Delaire","year":"1991","journal-title":"Protein Eng."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/359700a0","article-title":"Molecular Structure of the Acyl-Enzyme Intermediate in \u03b2-Lactam Hydrolysis at 1.7 \u00c5 Resolution","volume":"359","author":"Trynadka","year":"1992","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1021\/ja0259640","article-title":"An Ultrahigh Resolution Structure of TEM-1 Beta-Lactamase Suggests a Role for Glu166 as the General Base in Acylation","volume":"124","author":"Minasov","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"ref_26","unstructured":"Katsung, B.G., Masters, S.B., and Trevor, A.J. (2009). Beta Lactam and Other Cell Wall- and Membrane-Active Antibiotics: Textbook on Basics and Clinical Pharmacology, Tata Mcgraw Hill Education Private Limited. [11th ed.]."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2012.06796.x","article-title":"Metallo-\u03b2-Lactamase Structure and Function","volume":"1277","author":"Palzkill","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical Relevance of the ESKAPE Pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"A025247","DOI":"10.1101\/cshperspect.a025247","article-title":"b-Lactams and b-Lactamase Inhibitors: An Overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-micro-090110-102911","article-title":"Epidemiological Expansion, Structural Studies, and Clinical Challenges of New \u03b2-Lactamases from Gram-Negative Bacteria","volume":"65","author":"Bush","year":"2011","journal-title":"Ann. Rev. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated Functional Classification of b-Lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1128\/AEM.00463-15","article-title":"Recent Emergence of Escherichia coli with Cephalosporin Resistance Conferred by BlaCTX-M on Washington State Dairy Farms","volume":"81","author":"Davis","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1021\/bi701506h","article-title":"Irreversible Inhibition of the Mycobacterium Tuberculosis \u03b2-Lactamase by Clavulanate","volume":"46","author":"Hugonnet","year":"2007","journal-title":"Biochemistry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jmb.2005.02.010","article-title":"Atomic Resolution Structures of CTX-M \u03b2-Lactamases: Extended Spectrum Activities from Increased Mobility and Decreased Stability","volume":"348","author":"Chen","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1021\/bi990136d","article-title":"Structure of the SHV-1 \u03b2-Lactamase","volume":"38","author":"Kuzin","year":"1999","journal-title":"Biochemistry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1107\/S0907444905014356","article-title":"Structure of the Wild-Type TEM-1 [Beta]-Lactamase at 1.55 A and the Mutant Enzyme Ser70Ala at 2.1 A Suggest the Mode of Noncovalent Catalysis for the Mutant Enzyme","volume":"61","author":"Stec","year":"2005","journal-title":"Acta Crystallogr. Sect. D"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/AAC.02247-12","article-title":"Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas Aeruginosa AmpC b-Lactamases","volume":"57","author":"Lahiri","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.3390\/molecules17067266","article-title":"Hypervalent Nonbonded Interactions of a Divalent Sulfur Atom. Implications in Protein Architecture and the Functions","volume":"17","author":"Michio","year":"2012","journal-title":"Molecules"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","article-title":"The CTX-M \u03b2-Lactamase Pandemic","volume":"9","author":"Coque","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/332564a0","article-title":"Dissecting the Catalytic Triad of a Serine Protease","volume":"332","author":"Carter","year":"1988","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/cr960435y","article-title":"Binding Energy and Catalysis: The Implications for Transition-State Analogs and Catalytic An-Tibodies","volume":"97","author":"Mader","year":"1997","journal-title":"Chem. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/1568026023393679","article-title":"Cephalosporins in Veterinary Medicine\u2014Ceftiofur Use in Food Animals","volume":"2","author":"Hornish","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.21423\/bovine-vol51no2p190-199","article-title":"Survey of Treatment Practices on Midwest Dairy Farms","volume":"51","author":"Schuler","year":"2017","journal-title":"Bov. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-015-0578-3","article-title":"Effects of Ceftiofur Treatment on the Susceptibility of Commensal Porcine E. Coli\u2014Comparison between Treated and Untreated Ani-Mals Housed in the Same Stable","volume":"11","author":"Beyer","year":"2015","journal-title":"BMC Vet. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.theriogenology.2012.11.029","article-title":"Evaluation of Ceftiofur Crystalline Free Acid Sterile Suspension for Control of Metritis in High-Risk Lac-Tating Dairy Cows","volume":"79","author":"Mclaughlin","year":"2013","journal-title":"Theriogenology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1021\/acs.jmedchem.5b01215","article-title":"Exploring the Mechanism of Beta-Lactam Ring Protonation in the Class A Beta-Lactamase Acylation Mechanism Using Neutron and X-ray Crystallography","volume":"59","author":"Vandavasi","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1021\/bi100232q","article-title":"Biochemical and Structural Characterization of Mycobacterium Tuberculosis \u03b2-Lactamase with the Carbapenems Ertapenem and Doripenem","volume":"49","author":"Tremblay","year":"2010","journal-title":"Biochemistry"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Avillan, J., Ahmadvand, P., Lu, S.Y., Horton, J., Liu, J., Lofgren, E.T., Davis, M., Kang, C.H., and Call, D. (Appl. Environ. Microbiol., 2022). Excreted Antibiotics May Be Key to Emergence of Increasingly Efficient Antimicrobial Resistance, Appl. Environ. Microbiol., under review.","DOI":"10.1128\/aem.00791-22"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: A Comprehensive Python-Based System for Macromolecular Structure Solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Cryst. D Biol. Cryst."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and Development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Cryst. D Biol. Cryst."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/9\/5229\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:07:40Z","timestamp":1760137660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/9\/5229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["ijms23095229"],"URL":"https:\/\/doi.org\/10.3390\/ijms23095229","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]}}}